Bristol-Myers Squibb
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
CEOChristopher S. Boerner
CEOChristopher S. Boerner
Employees34,100
Employees34,100
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1933
Founded1933
Employees34,100
Employees34,100
BMY Key Statistics
Market cap97.38B
Market cap97.38B
Price-Earnings ratio17.63
Price-Earnings ratio17.63
Dividend yield5.19%
Dividend yield5.19%
Average volume14.14M
Average volume14.14M
High today$47.88
High today$47.88
Low today$46.85
Low today$46.85
Open price$46.99
Open price$46.99
Volume10.49M
Volume10.49M
52 Week high$63.33
52 Week high$63.33
52 Week low$39.35
52 Week low$39.35
BMY News
Simply Wall St 6d
Bristol-Myers Squibb Showcases Breakthrough Oncology Data at ASCO 2025 Meetingis advancing in oncology, as evidenced by its upcoming presentations at the 2025 ASCO Annual Meeting, which highlight its strong focus on cancer treatments. Thi...
Analyst ratings
71%
of 28 ratingsBuy
25%
Hold
71.4%
Sell
3.6%
People also own
Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.